CDDF Annual Conference
Challenges in clinical trial performance
6 – 8 February 2023, Hybrid Conference
SESSION 1: DIVERSITY IN CLINICAL TRIAL DATA
SESSION 2: REFLECTIONS ON CDDF WORKSHOPS AND JOINT ACTIVITIES IN 2022
SESSION 3: WHAT I SHOULD HAVE ASKED WHEN I STARTED MY CARREER IN CANCER DRUG DEVELOPMENT
The complete session 3 cannot be published because one of the speakers did not consent to have his recording shared.
Biologist perspective – Steve Wedge (Newcastle University, UK) – This speaker did not consent to have his lecture recording shared